Health
US
North America

Psychemedics

$14.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.68 (-4.46%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Psychemedics and other stocks, options, ETFs, and crypto commission-free!

About

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. Read More It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

Employees
250
Headquarters
Acton, Massachusetts
Founded
1986
Market Cap
83.93M
Price-Earnings Ratio
17.54
Dividend Yield
4.35
Average Volume
14.98K
High Today
$15.35
Low Today
$14.56
Open Price
$15.22
Volume
8.73K
52 Week High
$22.31
52 Week Low
$13.94

Collections

Health
US
North America

News

Simply Wall StMar 20

Some Psychemedics (NASDAQ:PMD) Shareholders Are Down 25%

Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market – but in the process, they risk under-performance. For example, the Psychemedics Corporation (NASDAQ:PMD) share price is down 25% in the last year. That’s well bellow the market return of 5.0%. The silver lining (for longer term investors) is that the stock is still 10% higher than it was three years ago. Even worse, it’s down 21% in about a month, which isn’t fun...

257
Yahoo FinanceMar 18

Those Who Purchased Psychemedics (NASDAQ:PMD) Shares A Year Ago Have A 26% Loss To Show For It

Investors can approximate the average market return by buying an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. That downside risk was realized by Psychemedics Corporation (NASDAQ:PMD) shareholders over the last year, as the share price declined 26%. That falls noticeably short of the market return of around 3.9%. Longer term investors have fared much better, since the share price is up 4.1% in three years. Even worse, it’s down 22% in about a mont...

719
Simply Wall StMar 8

Psychemedics Corporation (NASDAQ:PMD): 4 Days To Buy Before The Ex-Dividend Date

Important news for shareholders and potential investors in Psychemedics Corporation (NASDAQ:PMD): The dividend payment of US$0.18 per share will be distributed to shareholders on 25 March 2019, and the stock will begin trading ex-dividend at an earlier date, 13 March 2019. Should you diversify into Psychemedics and boost your portfolio income stream?

954

Earnings

$0.00
$0.08
$0.17
$0.25
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 23, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.